Work

First-in-human study of AMG 655, a pro-apoptotic TRAIL receptor-2 agonist, in adult patients with advanced solid tumors

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.3534

Authors: P. LoRusso, D. Hong, E. Heath, R. Kurzrock, D. Wang, M. Hsu, L. Goyal, J. Wiezorek, C. Storgard, R. Herbst

Institutions: Amgen (United States), The Barbara Ann Karmanos Cancer Institute

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2963392700

Cites:

Cited by: 50

Related to: 10